Earum Pharmaceuticals Limited IPO Details

Our Company is engaged in the pharmaceutical business involving marketing, trading and distribution of wide range of pharmaceutical formulation products such as anti-biotic drugs, anti-malarial drugs, anti-allergic & anti cold drugs, analgesic/ anti-pyretic & anti inflammatory drugs, dermatology products, cerebral activator drugs, neurological drugs, gastro intestinal drugs, steroids, gynecology drugs, calcium, multivitamins, anti-oxidants and injections. We offer wide range of pharmaceuticals formulation products, of which around 120 products are marketed by us under our own brand name, the manufacturing of which is outsourced by us to third parties. Apart from pharmaceutical formulation products, we also deal in trading of active pharmaceutical ingredients (API’s).

Mr. Bhumishth Narendrabhai Patel and Mrs. Payal Bhumishth Patel are the key promoters of our company. Our promoters collectively have more than four decades of experience among them. Our Company was originally incorporated as “Earum Pharmaceuticals Private Limited” on July 26, 2012 at Ahmedabad, Gujarat under the provisions of the Companies Act, 1956. On January 23, 2019, our company was converted into a Public Limited Company and consequently the name of our Company was changed from “Earum Pharmaceuticals Private Limited” to “Earum Pharmaceuticals Limited”.

Earum Pharmaceuticals Limited IPO Details
Issue Open	21-06-2019
Issue Close	26-06-2019
Allotment Date	02-07-2019
Unblocked Amount	03-07-2019
Listing Date	04-07-2019
Issue Share	18,48,000 Total Equity Share 96,000 Reserved by Market Maker 17,52,000 Equity Share
Issue Size	₹ 6.65 Cr
IPO Price Band	₹ 36
Minimum Share Bid	3000
Minimum Investment Amount [Rs]	₹ 1,08,000
Face Value	₹ 10
Retail Allocation	50%
Listing On	BSE SME

Earum Pharmaceuticals Limited IPO Grey Market Premium GMP]
Latest Update	Premium	Kostak	Subject to Sauda	Recommended
24-06-2019 : 08:00 AM	-	-	-	-

Earum Pharmaceuticals Limited IPO Financial details [in Rs, Cr]
Financial Year	Total Assets	Total Revenue	Total Expenses	Profit After Tax
FY-2014	-	-	-	-
FY-2015	-	-	-	-
FY-2016	8.79	18.63	18.47	0.09
FY-2017	11.08	23.70	23.45	0.15
FY-2018	20.53	35.85	34.60	0.85
31/12/18	27.42	34.50	33.30	0.86

Earum Pharmaceuticals Limited IPO Valuation Details
Earnings Per Share [EPS]	₹ 3.50
Price/Earnings [P/E] Ratio	10.29
Return on Net Worth [RoNW]	20.34 %
Net Asset Value [NAV]	₹ 136.46 Per Share

Earum Pharmaceuticals Limited IPO Subscription Details
As on Date	QIB/NII	RII	Total
Shared Offered	8,76,000	8,76,000	17,52,000
Day-1 [21-06-2019]	10,14,000 [1.16]	18,000 [0.02]	10,32,000 [0.77]
Day-2 [24-06-2019]	11,31,000 [1.29]	2,19,000 [0.25]	13,50,000 [0.77]
Day-3 [25-06-2019]	12,75,000 [1.46]	5,94,000 [0.68]	18,69,000 [1.07]
Day-4 [26-06-2019]	15,03,000 [1.72]	12,99,000 [1.48]	28,02,000 [1.60]

Earum Pharmaceuticals Limited IPO Grey Market Premium
Check Grey Market Premium :- Click Here

Earum Pharmaceuticals Limited IPO Allotment Status
Check Allotment Status :- Click Here

Live Subscription for Earum Pharmaceuticals Limited IPO
Check Live Subscription :- Click Here

Download Earum Pharmaceuticals Limited IPO RHP & ASBA e-Forms
Download RHP :- Click Here to Download Download e-Forms BSE:- Click Here to Download

Earum Pharmaceuticals Limited IPO Recommendations
Live IPO Team Recommendation:- Neutral

Earum Pharmaceuticals Limited IPO Contact Details
Earum Pharmaceuticals Limited G1, Ground Floor, V R Complex, Near Sanathal Cross Road, SP Ring Road, Sanathal, Ahmedabad, Gujarat-382210, India. Tel No: +91-79-48402525 E-mail: cs@earumpharma.com Website: https://www.earumpharma.com

Registrar of Earum Pharmaceuticals Limited IPO
BIGSHARE SERVICES PRIVATE LIMITED Address:-1st Floor, Bharat Tin Works Building, Opp. Vasant Oasis, Makwana Road, Marol, Andheri East, Mumbai - 400059 Tel No.:+91-022-62638200Fax No.: +91-022-62638299 Website:www.bigshareonline.com Email:ipo@bigshareonline.com Contact Person: Mr. Ashok Shetty SEBI Regn. No.: INR000001385

Lead Managers of Earum Pharmaceuticals Limited IPO
HEM SECURITIES LIMITED 904,A Wing, Naman Midtown, Senapati Bapat Marg, Elphinstone Road, Lower Parel, Mumbai-400013, India Tel. No.: +91- 022- 49060000Fax No.: +91- 022- 22625991 Website: www.hemsecurities.com Email: ib@hemsecurities.com Investor Grievance Email: redressal@hemsecurities.com Contact Person :Mr. Anil Bhargava SEBI Regn. No. INM000010981

Disclaimer:-

•       I request all investors, before applying for any IPO, please check the fundamentals and financial condition of the company and then applying to any IPO. •       www.liveipo.in will not be responsible for any kind of losses. So apply to any IPO at your risk •        We are not buying or selling any IPO forms regarding IPO Grey Market premium. We are only provide only recommendation of any IPO. •       Please do not subscribe to any IPO by just seeing the Grey Market Premium Price. It can change at any time.